Stay updated on Phase II Nivolumab Plus Ipilimumab in Sarcoma & Endometrial Clinical Trial
Sign up to get notified when there's something new on the Phase II Nivolumab Plus Ipilimumab in Sarcoma & Endometrial Clinical Trial page.

Latest updates to the Phase II Nivolumab Plus Ipilimumab in Sarcoma & Endometrial Clinical Trial page
- CheckyesterdayChange DetectedDifference0.3%
- Check8 days agoChange DetectedThe web page has removed extensive details about a clinical study involving nivolumab and ipilimumab for treating sarcoma and endometrial carcinoma, including study duration, patient criteria, and treatment protocols. Additionally, the revision number has been updated from v2.14.4 to v2.15.0.SummaryDifference52%
- Check15 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check23 days agoChange DetectedThe page has been updated to include information on Ewing Sarcoma and has been revised to version 2.14.3, while references to Osteosarcoma and the previous version 2.14.2 have been removed.SummaryDifference0.3%
- Check30 days agoChange DetectedDifference0.3%
- Check51 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
Stay in the know with updates to Phase II Nivolumab Plus Ipilimumab in Sarcoma & Endometrial Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase II Nivolumab Plus Ipilimumab in Sarcoma & Endometrial Clinical Trial page.